Suppressor of cytokine signaling 3 (SOCS3) limits damage-induced crypt hyper-proliferation and inflammation-associated tumorigenesis in the colon
- PMID: 17297444
- DOI: 10.1038/sj.onc.1210286
Suppressor of cytokine signaling 3 (SOCS3) limits damage-induced crypt hyper-proliferation and inflammation-associated tumorigenesis in the colon
Abstract
Intestinal injury or chronic inflammation induce cytokines that promote crypt regeneration and mucosal repair. If excessive or prolonged, such mechanisms may increase colon cancer risk. Factors that terminate or limit cytokine action in intestinal epithelial cells (IEC) may protect against crypt hyperplasia and neoplasia. We hypothesized that suppressor of cytokine signaling-3 (SOCS3) is such a factor. Mice with Vilin-promoter/Cre-recombinase (VC)-mediated IEC-specific SOCS3 gene disruption (VC/HO), WT/HO littermates with floxed but intact SOCS3 genes and VC/WT mice were studied. Colon was examined after acute dextran sodium sulfate (DSS)-induced mucosal injury or after azoxymethane (AOM) and chronic DSS. Signaling pathways were examined in colon, cultured IEC or colon cancer cell lines. VC/HO mice showed no basal phenotype. After acute DSS, VC/HO exhibited enhanced crypt proliferation and crypt hyperplasia and reduced transforming growth factor (TGF) beta expression in colon. Inflammation and mucosal damage were similar across genotypes. Following AOM/DSS, VC/HO mice had increased size, number and load of colonic tumors and increased STAT3 and nuclear factor-kappa B (NF-kappaB) activation in colon. In vitro, SOCS3 overexpression reduced proliferation, IL-6-mediated STAT3 activation and tumor necrosis factor (TNF) alpha-mediated NF-kappaB activation. We conclude that cytokine induction of SOCS3 normally provides an intrinsic mechanism to limit injury-induced crypt hyperproliferation and inflammation-associated colon cancer by regulating both STAT3 and NF-kappaB pathways.
Similar articles
-
Cytokine induction of tumor necrosis factor receptor 2 is mediated by STAT3 in colon cancer cells.Mol Cancer Res. 2011 Dec;9(12):1718-31. doi: 10.1158/1541-7786.MCR-10-0210. Epub 2011 Oct 12. Mol Cancer Res. 2011. PMID: 21994466 Free PMC article.
-
High suppressor of cytokine signaling-3 expression impairs STAT3-dependent protective effects of interleukin-22 in ulcerative colitis in remission.Inflamm Bowel Dis. 2015 Feb;21(2):241-50. doi: 10.1097/MIB.0000000000000267. Inflamm Bowel Dis. 2015. PMID: 25545374
-
Humanised antihuman IL-6R antibody with interferon inhibits renal cell carcinoma cell growth in vitro and in vivo through suppressed SOCS3 expression.Eur J Cancer. 2013 May;49(7):1715-24. doi: 10.1016/j.ejca.2012.11.038. Epub 2012 Dec 27. Eur J Cancer. 2013. PMID: 23274199
-
SOCS3 in immune regulation of inflammatory bowel disease and inflammatory bowel disease-related cancer.Cytokine Growth Factor Rev. 2012 Jun;23(3):127-38. doi: 10.1016/j.cytogfr.2012.04.005. Epub 2012 May 15. Cytokine Growth Factor Rev. 2012. PMID: 22591635 Review.
-
Epigenetic alterations in cholangiocarcinoma-sustained IL-6/STAT3 signaling in cholangio- carcinoma due to SOCS3 epigenetic silencing.Digestion. 2009;79 Suppl 1:2-8. doi: 10.1159/000167859. Epub 2009 Jan 20. Digestion. 2009. PMID: 19153483 Review.
Cited by
-
Control of Tyrosine Kinase Signalling by Small Adaptors in Colorectal Cancer.Cancers (Basel). 2019 May 14;11(5):669. doi: 10.3390/cancers11050669. Cancers (Basel). 2019. PMID: 31091767 Free PMC article. Review.
-
Loss of aryl hydrocarbon receptor suppresses the response of colonic epithelial cells to IL22 signaling by upregulating SOCS3.Am J Physiol Gastrointest Liver Physiol. 2022 Jan 1;322(1):G93-G106. doi: 10.1152/ajpgi.00074.2021. Epub 2021 Nov 10. Am J Physiol Gastrointest Liver Physiol. 2022. PMID: 34755534 Free PMC article.
-
Negative regulators of STAT3 signaling pathway in cancers.Cancer Manag Res. 2019 May 29;11:4957-4969. doi: 10.2147/CMAR.S206175. eCollection 2019. Cancer Manag Res. 2019. PMID: 31213912 Free PMC article. Review.
-
Quantitative assessment of gene promoter methylation in non-small cell lung cancer using methylation-sensitive high-resolution melting.Oncol Lett. 2018 May;15(5):7639-7648. doi: 10.3892/ol.2018.8321. Epub 2018 Mar 22. Oncol Lett. 2018. PMID: 29725463 Free PMC article.
-
Cyclophilin C-associated protein (CyCAP) knock-out mice spontaneously develop colonic mucosal hyperplasia and exaggerated tumorigenesis after treatment with carcinogen azoxymethane.BMC Cancer. 2009 Jul 24;9:251. doi: 10.1186/1471-2407-9-251. BMC Cancer. 2009. PMID: 19627619 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous